AstraZeneca | Investor Day Presentation Deck | 49 slides · page 12 of 49
The slide uses a biological process flow to explain the therapeutic rationale for C5 inhibition.
Conference presentation · propose_solution · present_framework · dense density
Slide locked Sign in to view
Slide schematic 7/7
callout 1/1 diagram 1/1 paragraph 2/2 source-note 1/1 title 2/2
Components 7
primary process paragraph paragraph source-note headline subtitle
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1